Search Results - Anna Bratcher

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    Quantitative SARS-CoV-2 Spike Receptor-Binding Domain and Neutralizing Antibody Titers in Previously Infected Persons, United States, January 2021–February 2022 by Anna Bratcher, Szu-Yu Kao, Kelly Chun, Christos J. Petropoulos, Adi V. Gundlapalli, Jefferson Jones, Kristie E.N. Clarke

    Published in Emerging Infectious Diseases (2024-11-01)
    Get full text
    Article


  2. 2

    Anti-nucleocapsid SARS-CoV-2 antibody seroprevalence in previously infected persons with immunocompromising conditions-United States, 2020-2022. by Anna Bratcher, Jefferson M Jones, William A Meyer, Rehan Waheed, Huda Yazgi, Aaron Harris, Adi V Gundlapalli, Kristie E N Clarke

    Published in PLoS ONE (2025-01-01)
    Get full text
    Article


  3. 3

    Anti-nucleocapsid SARS-CoV-2 antibody seroprevalence in previously infected persons with immunocompromising conditions—United States, 2020–2022 by Anna Bratcher, Jefferson M. Jones, William A. Meyer, Rehan Waheed, Huda Yazgi, Aaron Harris, Adi V. Gundlapalli, Kristie E. N. Clarke

    Published in PLoS ONE (2025-01-01)
    Get full text
    Article


  4. 4

    School mask policies and SARS-CoV-2 seroprevalence among school-age children—United States, September to December 2021 by Elise Nycz, Yangyang Deng, Miriam E. Van Dyke, Anna Bratcher, Jianrong Shi, Ronaldo Iachan, Kevin Berney, Jefferson M. Jones, Kristie E. N. Clarke

    Published in Microbiology Spectrum (2024-10-01)
    Get full text
    Article


  5. 5

    Changes in childhood vaccination coverage over time in the Democratic Republic of the Congo. by Vivian H Alfonso, Anna Bratcher, Hayley Ashbaugh, Reena Doshi, Adva Gadoth, Nicole Hoff, Patrick Mukadi, Angie Ghanem, Alvan Cheng, Sue Gerber, Guillaume Ngoie Mwamba, Jean Jacques Muyembe Tamfum, Emile Okitolonda Wemakoy, Anne W Rimoin

    Published in PLoS ONE (2019-01-01)
    Get full text
    Article


  6. 6

    Correction: Zoonotic risk factors associated with seroprevalence of Ebola virus GP antibodies in the absence of diagnosed Ebola virus disease in the Democratic Republic of Congo. by Anna Bratcher, Nicole A Hoff, Reena H Doshi, Adva Gadoth, Megan Halbrook, Patrick Mukadi, Kami Musene, Benoit Ilunga-Kebela, D'Andre Spencer, Matthew S Bramble, David McIlwain, J Daniel Kelly, Daniel Mukadi, Placide Mbala Kingebeni, Steve Ahuka, Emile Okitolonda-Wemakoy, Jean -Jacques Muyembe-Tamfum, Anne W Rimoin

    Published in PLoS Neglected Tropical Diseases (2022-05-01)
    Get full text
    Article


  7. 7

    Zoonotic risk factors associated with seroprevalence of Ebola virus GP antibodies in the absence of diagnosed Ebola virus disease in the Democratic Republic of Congo. by Anna Bratcher, Nicole A Hoff, Reena H Doshi, Adva Gadoth, Megan Halbrook, Patrick Mukadi, Kamy Musene, Benoit Ilunga-Kebela, D'Andre Spencer, Matthew S Bramble, David McIlwan, J Daniel Kelly, Daniel Mukadi, Placide Mbala Kingebeni, Steve Ahuka, Emile Okitolonda-Wemakoy, Jean-Jacques Muyembe-Tamfum, Anne W Rimoin

    Published in PLoS Neglected Tropical Diseases (2021-08-01)
    Get full text
    Article


Search Tools: